Search for: "Watson Pharmaceuticals, Inc"
Results 41 - 60
of 225
Sorted by Relevance
|
Sort by Date
15 Sep 2013, 9:42 pm
• Defendant: Watson Laboratories Inc. [read post]
23 Nov 2010, 9:54 pm
Noonan -- The Federal Trade Commission is nothing if not persistent in trying to eliminate "reverse payment" settlements in ANDA litigation, even going so far as to "forum shop" to do so, according to a brief by appellees Unimed Pharmaceuticals LLC, Abbott Products, Inc., and Watson Pharmaceuticals, Inc. [read post]
13 Sep 2015, 9:21 pm
• Defendants: Watson Laboratories, Inc.; Actavis, Inc.; Actavis Pharma, Inc. [read post]
13 Jan 2013, 9:06 pm
• Defendants: Apotex Inc.; Apotex Corp.; Sandoz, Inc.; Hi-Tech Pharmacal Co., Inc.; Watson Pharmaceuticals, Inc.; Watson Laboratories, Inc.; Watson Pharma, Inc. [read post]
25 Feb 2013, 11:00 pm
Watson Pharmaceuticals, Inc., the Federal Circuit reversed the district court’s finding that two Orange Book-listed patents for Cephalon’s FENTORA® product were invalid, but affirmed the district court’s finding that Watson’s ANDA product would not... [read post]
16 Jun 2020, 9:59 pm
Watson Laboratories Inc. and Galderma Laboratories, L.P. v. [read post]
7 Dec 2017, 9:34 pm
Seeking approval to market generic versions of Eli Lilly's Axiron® testosterone applicator, Defendants Perrigo Company and Perrigo Israel Pharmaceuticals Ltd., Actavis Laboratories UT, Inc., FKA Watson Laboratories Inc., Lupin Pharmaceuticals, Inc. and Lupin Ltd., and Amneal Pharmaceuticals LLC filed... [read post]
14 Feb 2013, 9:59 pm
By Kevin E. [read post]
9 Mar 2008, 7:26 pm
Duramed Pharmaceuticals, Inc. v. [read post]
27 Mar 2011, 9:28 pm
Watson Laboratories, Inc. [read post]
10 Mar 2013, 9:59 pm
Searle LLC; Pfizer Asia Pacific PTE, LTD.; • Defendants: Lupin Pharmaceuticals, Inc.; Teva Pharmaceuticals USA, Inc.; Mylan Pharmaceuticals Inc.; Watson Laboratories, Inc.; Apotex Inc.; Apotex Corp. [read post]
16 Jun 2013, 9:32 pm
Watson Laboratories Inc. et al. 1:13-cv-01015; filed June 6, 2013 in the District Court of Delaware • Plaintiff: Fresenius Kabi USA, LLC • Defendants: Watson Laboratories Inc.; Actavis Inc. [read post]
20 May 2010, 9:55 pm
Court of Appeals for the Second Circuit ruled that the "pay-for-delay" agreement between defendants Bayer AG and several generic drugmakers (including The Rugby Group, Watson Pharmaceuticals Inc., and Barr Laboratories Inc.) were not illegal under U.S. antitrust law and prevailing precedent. [read post]
9 Jan 2013, 11:01 pm
Watson Pharmaceuticals, Inc., to address whether and when “reverse payment” agreements made to settle ANDA litigation violate antitrust laws. [read post]
9 Apr 2009, 9:14 pm
District Court for the District of Delaware has ruled that Watson Pharmaceuticals, Inc.'s generic version of Concerta ® (methylphenidate hydrochloride extended-release tablets) does not infringe ALZA Corporation's and McNeill-PPC's patent covering the drug. [read post]
13 Feb 2010, 5:02 pm
Watson Pharmaceuticals, Inc., 2010 WL 446132 (D.N.J.) [read post]
9 Oct 2009, 9:11 am
Watson Pharmaceuticals Inc., Watson Laboratories, Inc. and Watson Pharma Inc. [read post]
5 Oct 2012, 11:43 am
Watson Pharmaceuticals, Inc. [read post]
12 Apr 2015, 7:45 pm
Supernus Pharmaceuticals, Inc. v. [read post]
19 Feb 2014, 6:57 am
• Watson Laboratories, Inc. [read post]
